Clinical trial
Consistency Lots Vaccine Study (V260-009)
NCT00092456 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092456 |
|---|---|
| Title | Consistency Lots Vaccine Study (V260-009) |
| Official title | Comparison of the Immunogenicity and Safety of Three Consistency Lots of V260 in Healthy Infants |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rotavirus Infections |
| Intervention type | Biological |
| Interventions | rotavirus vaccine, live, oral, pentavalent, Placebo |
| Enrollment | 793 |
| Start date | May 1, 2003 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Sep 27, 2004 |
| Last update posted | Oct 5, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: